Annual period ending Sep 27, 2025. These figures are calculated from the available SEC records and displayed independently of the period selected for the table.
These figures describe the results, not their causes. Read the original filing to investigate recurring operations, one-off effects and management’s outlook.
SEC · Reported statement presentation; original units are preserved.
Scale applies to monetary amounts; share counts and per-share values retain their units.
| Reported line item | TTM 2024Sep 28 | TTM 2024Dec 28 | TTM 2025Mar 29 | TTM 2025Jun 28 | TTM 2025Sep 27 | TTM 2025Dec 27 | TTM 2026Mar 28 | TTM 2026Jun 27 |
|---|---|---|---|---|---|---|---|---|
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing OperationUSD | 29.94B | 30.3B | 28.16B | 36.27B | 35.93B | 45.32B | 45.57B | 39.54B |
Cash & equivalentsUSD | 29.94B | 30.3B | 28.16B | 36.27B | 35.93B | 45.32B | 45.57B | 39.54B |
Net incomeUSD | 93.74B | 96.15B | 97.29B | 99.28B | 112.01B | 117.78B | 122.58B | 128.93B |
Depreciation & amortizationUSD | 11.45B | 11.68B | 11.5B | 11.48B | 11.7B | 11.83B | 12.61B | 13.1B |
Share-based compensationUSD | 11.69B | 11.98B | 12.24B | 12.54B | 12.86B | 13.17B | 13.47B | 13.71B |
Other Noncash Income (Expense)USD | 2.27B | 3.29B | 2.51B | 2.05B | 89M | -1.39B | -411M | 378M |
Increase (Decrease) in Accounts ReceivableUSD | 3.79B | 6.75B | 4.25B | 4.8B | 6.68B | 10.43B | 4.65B | 4.05B |
Increase (Decrease) in Other ReceivablesUSD | 1.36B | 2.76B | 4.35B | -1.1B | 347M | 732M | -490M | 8.23B |
Increase (Decrease) in InventoriesUSD | 1.05B | 694M | 241M | -136M | -1.4B | -974M | 542M | 5.28B |
Increase (Decrease) in Other Operating AssetsUSD | 11.73B | 9.34B | 11.66B | 12.22B | 9.2B | 20.39B | 19.16B | 19.35B |
Increase (Decrease) in Accounts PayableUSD | 6.02B | 3.89B | 8.13B | 2.71B | 902M | 8.42B | 3.21B | 14.18B |
Increase (Decrease) in Other Operating LiabilitiesUSD | 15.55B | 7.42B | 3.41B | 389M | -11.08B | 13.46B | 11.8B | 14.1B |
Operating cash flowUSD | 118.25B | 108.29B | 109.56B | 108.57B | 111.48B | 135.47B | 140.22B | 146.72B |
Payments to Acquire Debt Securities, Available-for-SaleUSD | 48.66B | 45B | 36.06B | 28.17B | 24.41B | 30.98B | 44.4B | 55.57B |
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-SaleUSD | 51.21B | 54.13B | 50.34B | 46.41B | 40.91B | 32.45B | 33.01B | 32.38B |
Proceeds from Sale of Debt Securities, Available-for-SaleUSD | 11.14B | 13.29B | 12.03B | 14.54B | 12.89B | 12.22B | 16.3B | 14.12B |
Capital expenditureUSD | 9.45B | 10B | 11.07B | 12.38B | 12.72B | 12.15B | 11.05B | 10.04B |
Payment for (Proceeds from) Other Investing ActivityUSD | 1.31B | 1.63B | 1.21B | 1.17B | 1.48B | 1.03B | 2.43B | 2.29B |
Investing cash flowUSD | 2.94B | 10.8B | 14.03B | 19.23B | 15.2B | 517M | -8.57B | -21.4B |
Payment, Tax Withholding, Share-Based Payment ArrangementUSD | 5.44B | 5.77B | 5.77B | 6B | 5.96B | 5.96B | 6.01B | 6.7B |
Dividends paidUSD | 15.23B | 15.27B | 15.31B | 15.36B | 15.42B | 15.49B | 15.55B | 15.64B |
Share repurchasesUSD | 94.95B | 98.42B | 101.11B | 95.66B | 90.71B | 91.81B | 78.2B | 82.23B |
Repayments of Long-Term DebtUSD | 9.96B | 10.97B | 10.82B | 12.24B | 10.93B | 12.09B | 14.84B | 9.4B |
Proceeds from (Repayments of) Commercial PaperUSD | 3.96B | 0 | 3.97B | 6.88B | -2.03B | 2M | -3.98B | -7.88B |
Proceeds from (Payment for) Other Financing ActivityUSD | -361M | -350M | -306M | -257M | -111M | -114M | -160M | -208M |
Financing cash flowUSD | -121.98B | -130.77B | -129.34B | -118.16B | -120.69B | -120.97B | -114.24B | -122.05B |
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued OperationUSD | -794M | -11.68B | -5.76B | 9.63B | 5.99B | 15.02B | 17.41B | 3.28B |
Income Taxes Paid, NetUSD | 26.1B | 37.5B | 43.25B | 44.2B | 43.37B | 28.15B | 32.08B | 32.59B |
The income statement tracks activity over a period, the balance sheet shows a position at a date, and cash flow explains movements in cash. A profit does not necessarily arrive as cash in the same period. Compare receivables, investment spending and financing alongside earnings.
Annual, quarterly and trailing-twelve-month views answer different questions. Seasonality can make adjacent quarters misleading. Check the fiscal dates and reporting currency before comparing figures; company-specific line items can differ from standard summaries.
Check whether changes in revenue are accompanied by changes in margins and operating cash flow. The figures alone cannot establish whether a movement came from pricing, acquisitions or a one-off item. Read the linked filing for management’s explanation and the accounting notes.
Valuations are estimates, not investment advice. Figures may use different source dates.
